AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Prelude Therapeutics Incorporated

$3.88 +$1.15 (+42.12%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$4.10
Day Range
$3.82$4.11
Year Range
$1.17$6.83
Market Cap
224.57M
AVG Volume
503.01K
Trailing/Forward PE
-4.91/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRLD Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q222.42M
26 Q116.72M
25 Q412.14M
25 Q310.5M
25 Q27M
25 Q17M
24 Q47M
24 Q33M
24 Q20
24 Q10
Net Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRLD Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-60.49M
26 Q1-77.8M
25 Q4-99.5M
25 Q3-111.77M
25 Q2-124.32M
25 Q1-127.83M
24 Q4-127.17M
24 Q3-131.52M
24 Q2-129.85M
24 Q1-125.55M
Operating Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRLD Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-67.4M
26 Q1-84.14M
25 Q4-104.57M
25 Q3-121.05M
25 Q2-135.01M
25 Q1-139.98M
24 Q4-139.71M
24 Q3-143.26M
24 Q2-142.27M
24 Q1-137.5M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PRLD

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

Prelude Therapeutics Incorporated
PRLD
Stockpicker

Video analysis: PRLD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRLD

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.